Stockscreener 앱 받기
42.01
1.83%
0.755
시간 외 거래:
42.66
0.655
+1.56%
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Rice Hall James & Associates LLC Reduces Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) - Finviz
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High – Time to Buy? - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Barry Quart Sells 20,129 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $500,714.88 in Stock - MarketBeat
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $500,715, According to a Recent SEC Filing - marketscreener.com
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $835,555, According to a Recent SEC Filing - marketscreener.com
Kiniksa Pharmaceuticals Executives Sell Shares - TradingView — Track All Markets
Kiniksa Pharmaceuticals (KNSA) director records option exercise and share sale - Stock Titan
Kiniksa Pharmaceuticals (KNSA) COO reports option exercise and share sale - Stock Titan
US High Growth Tech Stocks to Watch - simplywall.st
Braidwell LP Sells 860,329 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates Again - MSN
Nebula Research & Development LLC Has $1.93 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells 42,841 Shares of Stock - MarketBeat
Kiniksa Pharma CFO Ragosa sells shares worth $1.77m By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals CFO Sells Shares - TradingView — Track All Markets
Jump Financial LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Walleye Capital LLC - MarketBeat
Arrowstreet Capital Limited Partnership Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Fisher Asset Management LLC Has $2.83 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat
Traders Buy High Volume of Call Options on Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat
Franklin Resources Inc. Acquires 41,632 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - The Globe and Mail
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet - MSN
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighTime to Buy? - MarketBeat
AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
200,574 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Hillsdale Investment Management Inc. - MarketBeat
Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat
SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com South Africa
Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com
[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat
Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Jefferies London Healthcare Conference 2025Slideshow (NASDAQ:KNSA) 2025-11-18 - Seeking Alpha
Savant Capital LLC Invests $398,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Mark Ragosa Sells 19,900 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Rides ARCALYST Growth To Outpace The S&P 500 - Finimize
2.19%
0.08%
자본화:
|
볼륨(24시간):